The $198B vision and neurological diagnostics market is outdated, relying on bulky, clinic-based equipment that creates delays, high costs, and limited access to critical assessments. Many patients, athletes, and frontline workers go undiagnosed due to a lack of fast, affordable testing options—leading to preventable vision loss, untreated concussions, and missed early disease detection.
This company is breaking the barriers of traditional diagnostics with an AI-powered, smartphone-based platform that delivers real-time eye exams and neurological assessments remotely. Unlike conventional tools that require in-person visits and expensive hardware, this portable solution enables instant, clinically validated evaluations anywhere, making high-quality eye and brain health diagnostics as accessible as a mobile app.
With a strong IP portfolio, proven clinical accuracy, and a first-mover advantage in AI-driven eye and brain screening, the company is positioned to disrupt the industry. Currently raising to accelerate regulatory approvals, expand clinical adoption, and scale commercialization, this is a rare opportunity to invest in the future of decentralized healthcare.
View the deck through the link below. Some unique identifiers have been removed. For access to detailed materials, please reach to us or your point of contact, as full decks are only shared upon request to maintain confidentiality and exclusivity.
View Pitch Deck